Introduction:
Left ventricular outflow tract (LVOT) pseudoaneurysm is a rare but potentially fatal complication of aortic valve replacement (AVR), infective endocarditis (IE), and suture dehiscence. Since AVR is the established treatment for aggressive IE with septic emboli, such patients who undergo the procedure have an increased summative risk of this complication.1 Like LVOT pseudoaneurysm, left ventricular-aortic (LV-Ao) discontinuity is a severe and uncommon
manifestation of IE. For patients who have a long-standing history of endocarditis, peri-annular lesions in the aortic valve may rupture, leading to LV-Ao discontinuity. Additionally, after radical debridement for extensive IE, patients may present with iatrogenic LV-Ao discontinuity. In either case, LV-Ao discontinuity has high morbidity and mortality if left untreated.2